SuperGen, Inc. to Present at the Second Annual Piper Jaffray London Healthcare Conference
DUBLIN, Calif., June 14 /PRNewswire-FirstCall/ -- SuperGen Inc. today announced that Dr. James S. Manuso, President and CEO, will present a corporate overview and highlight SuperGen's recent developments at the Second Annual Piper Jaffray London Healthcare Conference at 10:40 a.m. BST on Thursday, June 21, 2007, at the Great Eastern Hotel in London.
A live Webcast of Dr. Manuso's presentation will be available on the Investor Relations section of the company's Web site at http://www.supergen.com. The Webcast will be archived for 90 days.
About SuperGen
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
Contacts: SuperGen SuperGen Timothy L. Enns Mary M. Vegh S.V.P., Corporate Communications & Manager, Investor Relations Business Development (925) 560-2845 (925) 560-0100 x111 mary.vegh@supergen.comtenns@supergen.com
SuperGen Inc.CONTACT: Timothy L. Enns, S.V.P., Corporate Communications & BusinessDevelopment, +1-925-560-0100 X111, tenns@supergen.com, or Mary M. VeghManager, Investor Relations, +1-925-560-2845, mary.vegh@supergen.com bothof SuperGen Inc.
Web site: http://www.supergen.com/